BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology - BioMed X Institute BioMed X Institute expands its collaboration with Merck KGaA, Darmstadt, Germany to a total of eight research programs. Call for application of the new research program 'Extrachromosomal DNA in Cancer' to open now.; Heidelberg, Germany, July 5, 2021 - BioMed X, a leading independent research institute, announced today the start of its eighth joint research program with Merck KGaA … bio.mx